Aaron C Spalding Selected Research

Aaron C Spalding Research Topics

Disease

20	Neoplasms (Cancer) 01/2024 - 01/2002
7	Pancreatic Neoplasms (Pancreatic Cancer) 08/2013 - 02/2007
4	Carcinoma (Carcinomatosis) 05/2017 - 01/2002
3	Glioblastoma (Glioblastoma Multiforme) 01/2024 - 04/2013
2	Breast Neoplasms (Breast Cancer) 01/2018 - 03/2007
1	Headache (Headaches) 12/2022
1	Necrosis 12/2022
1	Ependymoma 05/2022
1	Skin Neoplasms (Skin Cancer) 01/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018
1	Neuralgia (Stump Neuralgia) 07/2017
1	Rhabdoid Tumor (Rhabdoid Tumors) 05/2017
1	Brain Neoplasms (Brain Tumor) 05/2017
1	Pain (Aches) 01/2017
1	Brain Edema (Cerebral Edema) 10/2015
1	Weight Gain 12/2013
1	Rhabdomyosarcoma 11/2013
1	Cranial Nerve Diseases (Cranial Nerve Disorders) 11/2013
1	Embolism (Embolus) 04/2013
1	Wound Infection (Wound Infections) 04/2013
1	Head and Neck Neoplasms (Head and Neck Cancer) 11/2010
1	Adenocarcinoma 06/2010
1	Squamous Cell Carcinoma of Head and Neck 04/2009
1	Sarcoma (Soft Tissue Sarcoma) 01/2009
1	Adrenocortical Carcinoma 01/2009
1	Prostatic Neoplasms (Prostate Cancer) 05/2007

Drug/Important Bio-Agent (IBA)

2	Bevacizumab (Avastin)FDA Link 12/2022 - 04/2013
2	Temozolomide (Temodar)FDA LinkGeneric 10/2015 - 04/2013
2	Glycogen Synthase KinasesIBA 08/2013 - 11/2007
2	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2010 - 01/2002
2	Glycogen Synthase Kinase 3 betaIBA 05/2010 - 12/2008
1	GadoliniumIBA 01/2024
1	SteroidsIBA 12/2022
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	Lapatinib (GW572016)FDA Link 01/2018
1	ErbB Receptors (EGF Receptor)IBA 01/2018
1	Pain-FreeIBA 01/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2015
1	CytokinesIBA 10/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2013
1	Hypnotics and Sedatives (Sedatives)IBA 12/2013
1	IceIBA 11/2013
1	IntegrinsIBA 10/2011
1	Fibronectin ReceptorsIBA 10/2011
1	Integrin alpha5beta1IBA 10/2011
1	Aldehyde Dehydrogenase 1 FamilyIBA 08/2011
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2010
1	Aldehyde DehydrogenaseIBA 06/2010
1	LuciferasesIBA 06/2010
1	Docetaxel (Taxotere)FDA Link 06/2010
1	Phosphotransferases (Kinase)IBA 05/2010
1	beta CateninIBA 05/2010
1	Lithium ChlorideIBA 05/2010
1	Cisplatin (Platino)FDA LinkGeneric 04/2009
1	TOR Serine-Threonine KinasesIBA 01/2009
1	Sirolimus (Rapamycin)FDA Link 01/2009
1	MTOR InhibitorsIBA 01/2009
1	Somatomedin Receptors (Somatomedin Receptor)IBA 01/2009
1	DNA (Deoxyribonucleic Acid)IBA 01/2009
1	Mitotane (Lysodren)FDA Link 01/2009
1	Protein Kinase C betaIBA 12/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2008
1	CXC ChemokinesIBA 02/2008
1	Conditioned Culture MediaIBA 02/2008
1	ChemokinesIBA 02/2008
1	enzastaurinIBA 11/2007
1	Protein Kinases (Protein Kinase)IBA 11/2007
1	Biomarkers (Surrogate Marker)IBA 06/2006
1	MutagensIBA 01/2002
1	NF-kappa B (NF-kB)IBA 01/2002
1	Etoposide (VP 16)FDA LinkGeneric 01/2002
1	Apoptosis Regulatory ProteinsIBA 01/2002
1	Death Domain ReceptorsIBA 01/2002
1	Member 10c Tumor Necrosis Factor ReceptorsIBA 01/2002

Therapy/Procedure

12	Radiotherapy 01/2024 - 02/2007
9	Therapeutics 12/2022 - 06/2006
5	Drug Therapy (Chemotherapy) 08/2013 - 01/2002
3	Aftercare (After-Treatment) 08/2011 - 11/2007
2	Neoadjuvant Therapy 05/2017 - 06/2010
1	Re-Irradiation 01/2024
1	Particle Accelerators 07/2017
1	Craniotomy 04/2013